Cisplatin and doxorubicin toxicosis in dogs with osteosarcoma

Journal of Veterinary Internal Medicine

Volumn 17, Issue 5, 2003, Pages 668-673

  DeRegis, Carol J ^a   Moore, Antony S ^a,c   Rand, William M ^b   Berg, John ^a  

^a TUFTS UNIVERSITY   (United States)

^b Tufts Health Plan   (United States)

^c TUSVM   (United States)

Author keywords

Cancer; Canine; Dose escalation; Neoplasia

Indexed keywords

CISPLATIN; DOXORUBICIN; SODIUM CHLORIDE;

AMPUTATION; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOG DISEASE; INTOXICATION; MEDICAL RECORD; METASTASIS; NONHUMAN; OSTEOSARCOMA; REDUCTION; RETROSPECTIVE STUDY; SALURESIS; TOXICITY;

AMPUTATION; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CISPLATIN; COHORT STUDIES; DOG DISEASES; DOGS; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; EXTREMITIES; FEMALE; MALE; NEOPLASM STAGING; OSTEOSARCOMA; PROSPECTIVE STUDIES; RECORDS; RETROSPECTIVE STUDIES;

CANIS FAMILIARIS;

EID: 0141993029     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2003)017<0668:CADTID>2.3.CO;2     Document Type: Article

References (32)

1. Spodnick GJ, Berg J, Rand WM, et al. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). J Am Vet Med Assoc 1992;200:995-999.
2. Brodey RS, Abt DA. Results of surgical treatment in 65 dogs with osteosarcoma. J Am Vet Med Assoc 1976;168:1032-1035.
3. Straw RC, Withrow SJ, Richter SL, et al. Amputation and cisplatin for treatment of canine osteosarcoma. J Vet Intern Med 1991;5:205-210.
4. Mauldin GN, Matus RE, Withrow SJ, Patnaik AK. Canine osteosarcoma: Treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin. J Vet Intern Med 1988;2:177-180.
5. Shapiro W, Fossum TW, Kitchell BE, et al. Use of cisplatin for treatment of appendicular osteosarcoma in dogs. J Am Vet Med Assoc 1988;192:507-511.
6. Thompson JP, Fugent MJ. Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990). J Am Vet Med Assoc 1992;200:531-533.
7. Brodey RS, Riser WH. Canine osteosarcoma: A clinicopathologic study of 194 cases. Clin Orthop 1969;62:54-64.
8. Ogilvie GK, Straw RC, Jameson VJ, et al. Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991). J Am Vet Med Assoc 1993;202:304-306.
9. Berg J, Weinstein MJ, Schelling SH, Rand WM. Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990). J Am Vet Med Assoc 1992;200:2005-2008.
10. Kraegel SA, Madewell BR, Simonson E, Gregory CR. Osteogenic sarcoma and cisplatin chemotherapy in dogs: 16 cases (1986-1989). J Am Vet Med Assoc 1991;199:1057-1059.
11. Chun R, Kurzman ID, Couto CG, et al. Cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma: A pilot study. J Vet Intern Med 2000;14:495-498.
12. O'Brien MG, Withrow SJ, Straw RC. Recent advances in the treatment of canine appendicular osteosarcoma. Compend Contin Educ Pract Vet 1993;15:939-946.
13. Berg J, Weinstein MJ, Springfield DS, Rand WM. Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma. J Am Vet Med Assoc 1995;206:1555-1560.
14. DeVita VT, Schein PS. The use of drugs in combination for the treatment of cancer: Rationale and results. N Engl J Med 1973;288:998-1006.
15. Berg J, Gebhardt MC, Rand WM. Effect of timing of postoperative chemotherapy on survival of dogs with osteosarcoma. Cancer 1997;79:1343-1350.
16. Pratt CB, Champion JE, Senzer N, et al. Treatment of unresectable or metastatic osteosarcoma with cisplatin or cisplatin-doxorubicin. Cancer 1985;56:1930-1933.
17. Korn EL, Simon R. Using the tolerable-dose diagram in the design of phase I combination chemotherapy trials. J Clin Oncol 1993;11:794-801.
18. Hryniuk W, Wright FA. A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: Summation dose-intensity. J Clin Oncol 1998;16:3137-3147.
19. Korn EL, Simon R. Selecting dose-intense drug combinations: Metastatic breast cancer. Breast Cancer Res Treat 1991;20:155-166.
20. Simon R, Korn EL. Selecting drug combinations based on total equivalent dose (dose intensity). J Natl Cancer Inst 1990;82:1469-1476.
21. Fisher B, Gunduz N, Saffer EA. Influence of the interal between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 1983;43:1488-1492.
22. Fisher B, Gunduz N, Saffer EA. Interrelation between tumor cell proliferation and 17-fluoresceinated estrone binding after primary tumor removal, radiation, cyclophosphamide, or tamoxifen. Cancer Res 1983;43:5244-5247.
23. Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979;39:3861-3865.
24. Simpson-Herren L, Sanford AH, Holmquist JP. Effects of surgery on the cell kinetics of residual tumor. Cancer Treat Res 1976;60:1749-1760.
25. Bell RS, Jacobs J. Chemotherapy and surgery in a routine osteosarcoma. J Orthop Res 1992;10:720-728.
26. DeWys WD. Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors. Cancer Res 1972;32:374-379.
27. Bell RS, Roth YE, Gebhardt MC, et al. Timing of chemotherapy and surgery in a murine osteosarcoma model. Cancer Res 1988;48:5533-5538.
28. Rassnick KM, Frimberger AE, Wood CA, et al. Evaluation of ifosfamide for treatment of various canine neoplasms. J Vet Intern Med 2000;14:271-276.
29. Madewell BR, Leighton RL, Theilen GH. Amputation and doxorubicin for treatment of canine and feline osteogenic sarcoma. Eur J Cancer 1978;14:287-293.
30. Simon R. Clinical trials in cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 6th ed. Philadelphia, PA: Lippincott, Williams, and Wilkins; 2000:521-538.
31. Arrington KA, Legendre AM, Tabeling GS, Frazier DL. Comparison of body surface area-based and weight-based dosage protocols for doxorubicin administration in dogs. Am J Vet Res 1994;55:1587-1592.
32. Ogilvie GK, Moore AS, Curtis CR. Evaluation of cisplatin induced emesis in dogs with malignant neoplasia: 115 cases (1984-1987). J Am Vet Med Assoc 1989;195:1399-1403.